GRK5 and heart failure: In contrast to our findings, a study by Ramalingam et al. on Indian heart failure patients found that patients carrying GRK5 Leu41 variants and receiving beta-blocker therapy showed better ejection fraction and increased hospitalization-free survival compared with patients with wild-type genotype on beta-blockers [19].